Scientists Are Working On a New Pill That Could Help Your Dog Live Longer
If you've ever wished your fur babies could live longer, you may not have to wait too much longer for that dream to come true. A San Francisco biotech company called Loyal is developing what could become the first medication designed specifically to extend a dog's lifespan-and the FDA is taking it seriously. The drug, called LOY-002, has already cleared two of the three major hurdles required for approval, putting it on track for a potential market launch before the end of 2026.
This isn't about treating a specific disease like cancer or heart problems. Instead, the pill targets the biological processes of aging, aiming to slow the rate at which a dog's body deteriorates over time. For anyone who's watched a beloved pet go from playful to sedentary in what feels like overnight, the possibility of extending those good years changes everything.
Related: 4 Zodiac Signs That Make the Best Pet Parents
How the Drug Works
LOY-002 is a daily prescription pill designed for dogs aged 10 and older weighing at least 14 pounds. It works by targeting the hormone insulin-like growth factor 1 (IGF-1). While this hormone helps puppies grow, higher levels in older dogs are linked to faster cellular aging-especially in larger breeds, which naturally have shorter lifespans than small dogs.
By reducing IGF-1 activity, the pill aims to make aging dogs' bodies behave more like those of naturally long-lived, smaller breeds. Think of it as hitting the brakes on the aging process itself rather than treating individual conditions that show up along the way.
According to Celine Halioua, the company's founder and CEO, "Since founding Loyal six years ago, my goal has always been to get the first drug FDA approved for lifespan extension. This safety acceptance brings us very close to achieving that vision." The regulatory acceptance signals that the FDA believes the drug is likely to be both safe and effective for its intended purpose.
Related: Psychologist Says if You Give ‘People Names' to Your Pets, You Likely Have These 7 Traits
What This Means for Your Dog
The clinical trials have involved over 1,300 dogs across 70 veterinary clinics nationwide in what's being called the largest veterinary study of its kind. So far, the results have shown no significant adverse effects, even at doses much higher than those prescribed.
Early research suggests the pill could add roughly a year to a dog's life, which may not sound like much, but it's designed to extend healthspan-the number of years a dog stays active, mobile, and free from age-related illness, which, senior pet owners should know, is huge.
The drug is intended for dogs 10 and older, so it's specifically targeting elderly pets. But the implications extend beyond just older animals. If approved, LOY-002 would represent a fundamental shift in how veterinarians think about aging-moving from treating diseases after they appear to preventing them in the first place.
It's not here yet, and approval isn't guaranteed. But for dog owners watching their aging companions slow down, the possibility of a pill that could give them more years together is definitely worth considering.
Copyright 2026 The Arena Group, Inc. All Rights Reserved
This story was originally published May 15, 2026 at 2:29 PM.